Online articles
24 March 2014. Related: On the web.
400 vs 600 mg efavirenz study published in the Lancet
The Lancet, Early Online Publication, 10 February 2014 doi:10.1016/S0140-6736(13)62187-XCite
Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2962187-X/abstract